标题
HLA and pharmacogenetics of drug hypersensitivity
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 13, Issue 11, Pages 1285-1306
出版商
Future Medicine Ltd
发表日期
2012-08-24
DOI
10.2217/pgs.12.108
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Psoriasis-Associated Genetic Polymorphism in North Indian Population in the CCHCR1 Gene and in a Genomic Segment Flanking the HLA-C Region
- (2013) G. Gandhi et al. DISEASE MARKERS
- Abacavir induces loading of novel self-peptides into HLA-B*57
- (2012) Michael A. Norcross et al. AIDS
- Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong
- (2012) M.L.S. Chiu et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
- (2012) M A Martin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Avidity determines T-cell reactivity in abacavir hypersensitivity
- (2012) Jacqueline Adam et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome
- (2012) Chun-Yu Wei et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
- (2012) Patricia T. Illing et al. NATURE
- Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B*57:01 typing for eligibility to abacavir treatment in the Italian population
- (2012) Carla Badulli et al. PHARMACOGENOMICS
- Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions
- (2012) Mark McCormack et al. PHARMACOGENOMICS
- Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
- (2012) D. A. Ostrov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent
- (2011) Jing Yuan et al. AIDS
- HLA-Dependent Hypersensitivity Reaction to Nevirapine in Chinese Han HIV-Infected Patients
- (2011) Shicheng Gao et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Drug Hypersensitivity and Human Leukocyte Antigens of the Major Histocompatibility Complex
- (2011) Mandvi Bharadwaj et al. Annual Review of Pharmacology and Toxicology
- HLA-B Alleles and Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Han Chinese Population
- (2011) Yi-Wu Shi et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
- (2011) Ratchadaporn Somkrua et al. BMC Medical Genetics
- Rapid HCP5 single-nucleotide polymorphism genotyping: A simple allele-specific PCR method for prediction of hypersensitivity reaction to Abacavir
- (2011) Cristian A. Galván et al. CLINICA CHIMICA ACTA
- Genome-wide Association Study Identifies Variations in 6p21.3 Associated With Nevirapine-Induced Rash
- (2011) Soranun Chantarangsu et al. CLINICAL INFECTIOUS DISEASES
- The Phenotype Standardization Project: Improving Pharmacogenetic Studies of Serious Adverse Drug Reactions
- (2011) M Pirmohamed et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic association studies in drug-induced liver injury
- (2011) Ann K. Daly et al. DRUG METABOLISM REVIEWS
- Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
- (2011) Sae-Hoon Kim et al. EPILEPSY RESEARCH
- Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients
- (2011) Yan Zhang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles
- (2011) M. Isabel Lucena et al. GASTROENTEROLOGY
- Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus–positive patients from southern Alberta
- (2011) Noureddine Berka et al. HUMAN IMMUNOLOGY
- Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?
- (2011) M. H. Lee et al. INTERNAL MEDICINE JOURNAL
- Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
- (2011) Choong-Chor Chang et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis
- (2011) A. F. Cristallo et al. International Journal of Immunogenetics
- Immune pathomechanism of drug hypersensitivity reactions
- (2011) Werner J. Pichler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome
- (2011) Tai-Ming Ko et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions
- (2011) Chaichon Locharernkul et al. JOURNAL OF CLINICAL NEUROSCIENCE
- HLA-DQA1*02:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer
- (2011) Colin F. Spraggs et al. JOURNAL OF CLINICAL ONCOLOGY
- HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population
- (2011) Hiroyuki NIIHARA et al. JOURNAL OF DERMATOLOGY
- HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency
- (2011) J.-W. Jung et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- HLA-B*1502 Screening and Toxic Effects of Carbamazepine
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
- (2011) Pei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
- (2011) Emmanuelle Génin et al. Orphanet Journal of Rare Diseases
- Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans
- (2011) Hye-Ryun Kang et al. Pharmacogenetics and Genomics
- Association of the genetic marker for abacavir hypersensitivity HLA-B*5701 with HCP5 rs2395029 in Mexican Mestizos
- (2011) Francisco Sanchez-Giron et al. PHARMACOGENOMICS
- Phenytoin-induced Stevens–Johnson syndrome with negative HLA-B*1502 allele in mainland China: Two cases
- (2011) Fa-Yun Hu et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland
- (2011) Qian Wang et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity
- (2011) L. Kostenko et al. TISSUE ANTIGENS
- HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
- (2011) Kongkiat Kulkantrakorn et al. Pain Practice
- Trivalent Adenovirus Type 5 HIV Recombinant Vaccine Primes for Modest Cytotoxic Capacity That Is Greatest in Humans with Protective HLA Class I Alleles
- (2011) Stephen A. Migueles et al. PLoS Pathogens
- HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
- (2010) Nahoko Kaniwa et al. EPILEPSIA
- Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
- (2010) Wichittra Tassaneeyakul et al. EPILEPSIA
- Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China
- (2010) X.T. Wu et al. EPILEPSY & BEHAVIOR
- Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population
- (2010) Dong-Mei An et al. EPILEPSY RESEARCH
- Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya
- (2010) PJ Peters et al. HIV MEDICINE
- Introduction of pharmacogenetic screening for the human leucocyte antigen (HLA) B*5701 variant in Polish HIV-infected patients
- (2010) M Parczewski et al. HIV MEDICINE
- Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
- (2010) Takeshi Ozeki et al. HUMAN MOLECULAR GENETICS
- Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701
- (2010) S. Rodriguez-Novoa et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Candidate Gene Analysis Identifies a Polymorphism inHLA-DQB1Associated With Clozapine-Induced Agranulocytosis
- (2010) Maria C. Athanasiou et al. JOURNAL OF CLINICAL PSYCHIATRY
- A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
- (2010) Jonathan B Singer et al. NATURE GENETICS
- HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity
- (2010) K. D. Rosenman et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Pharmacogenetics of drug hypersensitivity
- (2010) Elizabeth J Phillips et al. PHARMACOGENOMICS
- Common risk allele in aromatic antiepileptic-drug induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Han Chinese
- (2010) Shuen-Iu Hung et al. PHARMACOGENOMICS
- HLA-B*5901is strongly associated with methazolamide-induced Stevens–Johnson syndrome/toxic epidermal necrolysis
- (2010) Sae-Hoon Kim et al. PHARMACOGENOMICS
- HLA associations in aurothioglucose- and D-penicillamine-induced haematotoxic reactions in rheumatoid arthritis
- (2010) F. Speerstra et al. TISSUE ANTIGENS
- HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz
- (2009) Zulma G Vitezica et al. AIDS
- First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America
- (2009) Benjamin Young et al. AIDS
- Strontium ranelate-induced DRESS syndrome: first two case reports
- (2009) A. P. Jonville-Béra et al. ALLERGY
- Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms
- (2009) Majed Eshki et al. ARCHIVES OF DERMATOLOGY
- Metabolic and Chemical Origins of Cross-Reactive Immunological Reactions to Arylamine Benzenesulfonamides: T-Cell Responses to Hydroxylamine and Nitroso Derivatives
- (2009) J. Luis Castrejon et al. CHEMICAL RESEARCH IN TOXICOLOGY
- HLA-B*5701 screening prior to abacavir prescription: Clinical and laboratory aspects
- (2009) David Nolan CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions
- (2009) Hiroko Ikeda et al. EPILEPSIA
- Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population
- (2009) TW Mahungu et al. HIV MEDICINE
- The Variable Clinical Picture of Drug-Induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms in Relation to the Eliciting Drug
- (2009) Yoko Kano et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Association of HLA-BFNx011502 allele and carbamazepine-inducedStevens-Johnson syndromeamong Indians
- (2009) TimirY Mehta et al. Indian Journal of Dermatology Venereology & Leprology
- The Convenience of Flow Cytometry for HLA-B*5701 Screening to Prevent Abacavir Hypersensitivity Reactions
- (2009) Paolo Airo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Oxcarbazepine-induced Stevens-Johnson Syndrome: A Case Report
- (2009) Lung-Chang Lin et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
- (2009) Ann K Daly et al. NATURE GENETICS
- Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
- (2009) P. Musette et al. OSTEOPOROSIS INTERNATIONAL
- High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients
- (2009) Gbenga R. Kazeem et al. Pharmacogenetics and Genomics
- HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients
- (2009) Soranun Chantarangsu et al. Pharmacogenetics and Genomics
- Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population
- (2009) Wichittra Tassaneeyakul et al. Pharmacogenetics and Genomics
- Genetic Association Studies in Drug-Induced Liver Injury
- (2009) Ann Daly et al. SEMINARS IN LIVER DISEASE
- HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients
- (2009) Sirirat Likanonsakul et al. AIDS Research and Therapy
- A review of drug patch testing and implications for HIV clinicians
- (2008) Neil H Shear et al. AIDS
- The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV
- (2008) Bruce R Schackman et al. AIDS
- Drug-induced lupus erythematosus
- (2008) Camilla Dalle Vedove et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- High Sensitivity of Human Leukocyte Antigen–B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients
- (2008) Michael Saag et al. CLINICAL INFECTIOUS DISEASES
- Should HLA‐B*5701 Screening Be Performed in Every Ethnic Group before Starting Abacavir?
- (2008) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
- (2008) Chaichon Locharernkul et al. EPILEPSIA
- Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity
- (2008) Diana Chessman et al. IMMUNITY
- TheHCP5Single‐Nucleotide Polymorphism: A Simple Screening Tool for Prediction of Hypersensitivity Reaction to Abacavir
- (2008) Sara Colombo et al. JOURNAL OF INFECTIOUS DISEASES
- Oxcarbazepine-induced Stevens-Johnson syndrome in a patient withHLA-B*1502genotype
- (2008) Y-C Chen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
- (2008) Christine Lonjou et al. Pharmacogenetics and Genomics
- HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis
- (2008) Nahoko Kaniwa et al. PHARMACOGENOMICS
- Carbamazepine,HLA-B*1502and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
- (2008) P Brent Ferrell et al. PHARMACOGENOMICS
- Flucloxacillin-induced liver injury
- (2008) Elise Andrews et al. TOXICOLOGY
- Pharmacogenetics of aspirin-intolerant asthma
- (2007) Seung-Hyun Kim et al. PHARMACOGENOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started